These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34612079)

  • 21. Multicenter study of repeat epinephrine treatments for food-related anaphylaxis.
    Rudders SA; Banerji A; Corel B; Clark S; Camargo CA
    Pediatrics; 2010 Apr; 125(4):e711-8. PubMed ID: 20308215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
    Adamic K; Zidarn M; Bajrovic N; Erzen R; Kopac P; Music E
    Wien Klin Wochenschr; 2009; 121(9-10):357-60. PubMed ID: 19562302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoinjectors Preferred for Intramuscular Epinephrine in Anaphylaxis and Allergic Reactions.
    Campbell RL; Bellolio MF; Motosue MS; Sunga KL; Lohse CM; Rudis MI
    West J Emerg Med; 2016 Nov; 17(6):775-782. PubMed ID: 27833688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy safety: what have we learned from surveillance surveys?
    Kannan JA; Epstein TG
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):381-8. PubMed ID: 23636820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A second dose of epinephrine for anaphylaxis: how often needed and how to carry.
    Kelso JM
    J Allergy Clin Immunol; 2006 Feb; 117(2):464-5. PubMed ID: 16461150
    [No Abstract]   [Full Text] [Related]  

  • 28. Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register.
    Grabenhenrich LB; Dölle S; Ruëff F; Renaudin JM; Scherer K; Pföhler C; Treudler R; Koehli A; Mahler V; Spindler T; Lange L; Bilò MB; Papadopoulos NG; Hourihane JOB; Lang R; Fernández-Rivas M; Christoff G; Cichocka-Jarosz E; Worm M
    J Allergy Clin Immunol Pract; 2018; 6(6):1898-1906.e1. PubMed ID: 29606638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study.
    Asero R; Antonicelli L; Arena A; Bommarito L; Caruso B; Colombo G; Crivellaro M; De Carli M; Della Torre E; Della Torre F; Heffler E; Lodi Rizzini F; Longo R; Manzotti G; Marcotulli M; Melchiorre A; Minale P; Morandi P; Moreni B; Moschella A; Murzilli F; Nebiolo F; Poppa M; Randazzos S; Rossi G; Senna GE
    Eur Ann Allergy Clin Immunol; 2010 Feb; 42(1):25-31. PubMed ID: 20355362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Therapies in Anaphylaxis: Alternatives to Intramuscular Administration of Epinephrine.
    Boswell B; Rudders SA; Brown JC
    Curr Allergy Asthma Rep; 2021 Mar; 21(3):18. PubMed ID: 33666759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse reactions associated with skin testing and immunotherapy.
    Lockey RF
    Allergy Proc; 1995; 16(6):293-6. PubMed ID: 8747313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic reactions to subcutaneous immunotherapy: Effects of dosing and aeroallergen content.
    Mustafa SS; Bingemann T; Blue H; Conn K; Hanley T; Ramsey A
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):284-287. PubMed ID: 31276805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy.
    Dhamija Y; Epstein TEG; Bernstein DI
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):105-119. PubMed ID: 34823741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel routes for allergen immunotherapy: safety, efficacy and mode of action.
    Moingeon P; Mascarell L
    Immunotherapy; 2012 Feb; 4(2):201-12. PubMed ID: 22339462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prehospital Administration of Epinephrine in Pediatric Anaphylaxis.
    Carrillo E; Hern HG; Barger J
    Prehosp Emerg Care; 2016; 20(2):239-44. PubMed ID: 26555274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors.
    Sánchez-Borges M; Bernstein DI; Calabria C
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):25-39. PubMed ID: 31761119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
    Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective safety study of allergen immunotherapy in daily clinical practice.
    Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Herrera I; Sánchez-Morillas L; Pérez-Pimiento A
    Allergol Immunopathol (Madr); 2004; 32(5):278-83. PubMed ID: 15456624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of anaphylactic shock].
    Reimers A; Müller U
    Ther Umsch; 2001 May; 58(5):325-8. PubMed ID: 11407236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.